Wednesday, October 16, 2019 10:26:26 PM
After Q&A we went to the PDL tour. It was just before the tour that Richard congratulated me for asking the questions about the reactors. He said that was the first time in 25 years that he had heard a question about the reactors at an ASM. (A couple of the board members also thanked me for the reactor question) Then Richard he told me the new Thermo Fisher reactors were actually square. He recently saw them at a conference.
On to the tour…..
The micro-reactors (30 new bench scale controllers standardizing with a 3L micro-reactor) in 8000 sqf in the Franklin building allow the development timelines to be compressed. The new PDL also has a 50L and 200L pilot plant (mid-range/intermediate scale). The bench-scale allows results of many runs (usually 3L) to be over-laid to show consistency and to set parameters and ranges for the process.
I had a question about how they would scale up from this leading-edge, industry-standard, 3L (or 15L) micro-reactors and controllers to the newly designed square reactors from Thermo Fisher. They said the objective in the lab is to remove these engineering differences. Engineering differences exist between different manufacturers (Thermo Fisher v Mobius), different sizes (200L v 2000L), as well as different designs (cylinder v square or stainless steel v single use). So they use dimensionless parameters. Thermo Fisher will be asked to show them that these parameters are achievable with their reactors. The vendor will be asked to provide scaled-down (pilot/intermediate) models of the squared reactors.
Samples from the bench reactors and from the pilot sized reactors are taken constantly to be analyzed to track variances and consistency. That allows the parameter ranges to be identified statistically. The product from the pilot-scale reactor belongs to the client to use as they need. The client can run preclinical trials with this pilot size batch.
After harvesting the material from the pilot batch they take it to the downstream lab where the material is purified by running it through columns of resin. That purification process can then easily be scaled up to manufacturing sized columns.
We know the facts so your FUD (Fear Uncertainty and Doubt) is useless here.
Recent CDMO News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 08:45:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 11:40:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:37:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:22:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:21:22 AM
- Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference • GlobeNewswire Inc. • 09/12/2024 08:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/09/2024 08:43:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:19:30 PM
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 • GlobeNewswire Inc. • 09/09/2024 08:05:31 PM
- U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns • IH Market News • 09/09/2024 10:09:14 AM
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 • GlobeNewswire Inc. • 09/03/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:30:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/28/2024 08:34:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/28/2024 08:32:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2024 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM